Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Santen Pharmaceutical (PK) (SNPHY)

Santen Pharmaceutical Company (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SNPHY
DateTimeSourceHeadlineSymbolCompany
17/06/202112:10Dow Jones NewsAerie Completes Enrollment of Phase 3 Glaucoma Study in JapanUSOTC:SNPHYSanten Pharmaceutical Company (PK)
29/09/201718:44Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:SNPHYSanten Pharmaceutical Company (PK)
07/03/201620:22Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:SNPHYSanten Pharmaceutical Company (PK)
15/04/201515:03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:SNPHYSanten Pharmaceutical Company (PK)
30/03/201519:38Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:SNPHYSanten Pharmaceutical Company (PK)
24/03/201520:07Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:SNPHYSanten Pharmaceutical Company (PK)
16/10/201418:30Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:SNPHYSanten Pharmaceutical Company (PK)
13/05/201412:40Dow Jones NewsMerck to Sell Some Ophthalmology AssetsUSOTC:SNPHYSanten Pharmaceutical Company (PK)
04/02/201312:49Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:SNPHYSanten Pharmaceutical Company (PK)
30/01/201322:01Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:SNPHYSanten Pharmaceutical Company (PK)
 Showing the most relevant articles for your search:USOTC:SNPHY